Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.

Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.

In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain. 

In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.

Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."

For further information on Rycarfa, please contact Dechra on 01939 211200.

*Gfk sales data 1 July 2011

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.